Mushtaq Ahmed | Life Sciences | Best Researcher Award

Published on by TOT Awards

Prof. Mushtaq Ahmed | Life Sciences | Best Researcher Award

University of Science and Technology, Bannu | Pakistan

Academic Background

Prof. Dr. Mushtaq Ahmed holds a PhD in Biochemistry and Toxicology from the Federal University of Santa Maria, Brazil, and completed his postdoctoral research at Lund University, Sweden, focusing on enzymatic hydrolysis and bioactive compounds derived from agricultural waste. He has maintained a consistent first-class academic record throughout his career and is an HEC-approved PhD supervisor. His Google Scholar profile reflects over 2,500 citations with an h-index of 24 and an i10-index of 52, while Scopus highlights his strong and growing international research visibility. These metrics underscore his influence in biochemical and toxicological research, showcasing a well-established scientific reputation supported by impactful publications and extensive academic collaborations.

Research Focus

Prof. Dr. Mushtaq Ahmed primary research interests include biochemical toxicology, enzyme kinetics, oxidative stress mechanisms, and pharmacological exploration of natural bioactive compounds. His work bridges fundamental biochemistry with applied biotechnology, aiming to develop therapeutic and environmentally sustainable biological solutions.

Work Experience

Prof. Dr. Mushtaq Ahmed is currently serving as Professor and Chairman of the Department of Biotechnology at the University of Science and Technology, Bannu, where he also holds the position of Dean of the Faculty of Arts and Humanities. With more than twenty years of academic and research experience, he has previously served as Associate Professor, Director of ORIC, and Chief Proctor. His career reflects a deep commitment to teaching, research supervision, and institutional development in the field of biotechnology and life sciences.

Key Contributions

Prof. Dr. Mushtaq Ahmed has made substantial contributions to the understanding of enzyme inhibition, oxidative stress biology, and the pharmacological potential of natural compounds. His multidisciplinary research has advanced drug design models and therapeutic approaches derived from biochemical analysis and bioactive plant compounds.

Awards & Recognition

Prof. Dr. Mushtaq Ahmedhas received multiple prestigious awards recognizing his excellence in academia and research. He is a two-time recipient of the HEC Best University Teacher Award and has also been honored with the Best Researcher Award for his outstanding scientific contributions and international publications. These accolades highlight his leadership in advancing biotechnology research and his dedication to scientific innovation and mentorship.

Professional Roles & Memberships

Prof. Dr. Mushtaq Ahmed has served on several high-level academic and administrative committees including the Syndicate, Finance and Planning Committee, and the Advanced Studies and Research Board of UST Bannu. Additionally, he has acted as a reviewer for renowned international journals such as Life Science, Physiologia Plantarum, Chemico-Biological Interactions, and Ecotoxicology, contributing to the global advancement of scientific standards and peer review integrity.

Profile

Google Scholar

Featured Publications

  • Khan, R. A., Khan, M. R., Sahreen, S., & Ahmed, M. (2012). Evaluation of phenolic contents and antioxidant activity of various solvent extracts of Sonchus asper (L.) Hill. Chemistry Central Journal, 6(1), 12.

  • Khan, R. A., Khan, M. R., Sahreen, S., & Ahmed, M. (2012). Assessment of flavonoids contents and in vitro antioxidant activity of Launaea procumbens. Chemistry Central Journal, 6(1), 43.

  • Abbasi, A. M., Khan, M. A., Ahmed, M., & Zafar, M. (2010). Herbal medicines used to cure various ailments by the inhabitants of Abbottabad district, North West Frontier Province, Pakistan. Indian Journal of Traditional Knowledge, 9(1), 175–183.

  • Bagatini, M. D., Martins, C. C., Battisti, V., Gasparetto, D., Da Rosa, C. S., … [other authors]. (2011). Oxidative stress versus antioxidant defenses in patients with acute myocardial infarction. Heart and Vessels, 26(1), 55–63.

  • Ahmed, M., Rocha, J. B. T., Corrêa, M., Mazzanti, C. M., Zanin, R. F., Morsch, A. L. B., … [other authors]. (2006). Inhibition of two different cholinesterases by tacrine. Chemico-Biological Interactions, 162(2), 165–171.

Impact Statement / Vision

Prof. Dr. Mushtaq Ahmed envisions strengthening biotechnology and biochemical research through innovation, collaboration, and applied discovery. His vision emphasizes bridging scientific inquiry with societal benefits by promoting sustainable and health-oriented research. As an academic leader and accomplished researcher, he continues to inspire excellence, integrity, and scientific curiosity among emerging scholars in Pakistan and beyond.

EMMANUEL SCALAIS | Medicine and Health Sciences | Outstanding Scientist Award

Published on by TOT Awards

Dr.EMMANUELSCALAIS|MedicineandHealth Sciences| Outstanding Scientist Award

MD at NEPE, Luxembourg.

Dr. Emmanuel Scalais is the Chief Physician of the Pediatric Neurology Department at Centre Hospitalier de Luxembourg (CHL)He has authored 82 publications and has been cited 2,877 times in the field of pediatric neurology.His clinical expertise includes conditions such as homocystinuria, vitamin B12 deficiency anemia, and exocrine pancreatic insufficiency.

professional profiles📖

Education 🎓

Secondary School: Humanity Greco-Latine (June 1972), Collège du Sacré-Coeur, Charleroi, BelgiumHigh School: Université Catholique de LouvainBaccalauréat en Philosophie: Magna cum Laude (June 1975)Doctor of Medicine: Laude (June 1979)

work Experience💼

1988-2002: Pediatric Neurologist, CHC Espérance & Saint Vincent, Liège, Belgium (Full-time)Lecturer: Pediatric Neurology Course for nurses at “School of Sainte-Julienne,” LiègeLecturer: “Medical Approach of Handicap” in Orthopédagogie2003-2024: Pediatric Neurologist, Centre Hospitalier de Luxembourg, Department of Pediatrics (Full-time)Head of Pediatric Neurology Division (2014-2018, 2018-2024)Lecturer: Pediatric Neurology Course for nurses at “Lycée Technique pour Professions de Santé” (2006-2024)

Research Focus

Dr. Scalais has authored numerous peer-reviewed articles, with a focus on pediatric neurology, metabolic disorders, and neonatal brain function. Notable contributions include:Research on phenobarbital’s effects on cerebral blood flow in newbornsStudies on very long-chain acyl-CoA dehydrogenase deficiency as a cause of neonatal sudden infant deathInvestigations into early myoclonic epilepsy linked to CoQ10 deficiencyDiagnostic and prognostic value of evoked potentials in neonatal hypoxiaCase studies on mitochondrial disorders, such as Leigh’s encephalopathy and POLG mutationsHydroxocobalamin dose intensification in early-onset cobalamin metabolism defects

Conclusion

Dr. Scalais based on his , , and . While increasing could further strengthen his profile, his current body of work already demonstrates and .is highly suitable for this awardsignificant contributions to pediatric neurology researchclinical impactinternational collaborationshigh-impact publications, principal investigator roles, and research fundingoutstanding scientific meritlong-term dedication to pediatric neurology

📚Publications to Noted

  • Scalais E, Beharry K, Papageorgiou A, Bureau M, Aranda JV (1992). Effects of phenobarbital on cerebral blood flow in the newborn piglet. Developmental Pharmacology and Therapeutics, 19(1), 10-18. [doi: 10.1159/000457457]

  • Scalais E, Bottu J, Wanders RJ, Ferdinandusse S, Waterham HR, De Meirleir L (2015). Familial very long chain acyl-CoA dehydrogenase deficiency as a cause of neonatal sudden infant death: improved survival by prompt diagnosis. American Journal of Medical Genetics Part A, 167A(1), 211-214. [doi: 10.1002/ajmg.a.36803]

  • Scalais E, Chafai R, Van Coster R, Bindl L, Nuttin C, Panagiotaraki C, Seneca S, Lissens W, Ribes A, Geers C, Smet J, De Meirleir L (2013). Early myoclonic epilepsy, hypertrophic cardiomyopathy and subsequently a nephrotic syndrome in a patient with CoQ10 deficiency caused by mutations in para-hydroxybenzoate-polyprenyl transferase (COQ2). European Journal of Paediatric Neurology, 17(6), 625-630. [doi: 10.1016/j.ejpn.2013.05.013]

  • Scalais E, Connerotte AC, Despontin K, Biver A, Ceuterick-de Groote C, Alders M, Kolivras A, Hachem JP, De Meirleir L (2016). Shwachman-Diamond syndrome presenting with early ichthyosis, associated dermal and epidermal intracellular lipid droplets, hypoglycemia, and later distinctive clinical SDS phenotype. American Journal of Medical Genetics Part A, 170(7), 1799-1805. [doi: 10.1002/ajmg.a.37673]

  • Scalais E, Francois A, Nuttin C (1996). [Diagnostic and prognostic value of evoked potentials facing cerebral hypoxia in newborn infants]. Archives de Pédiatrie, 3 Suppl 1, 251s-253s. [doi: 10.1016/0929-693x(96)86058-1]

  • Scalais E, Francois B, Schlesser P, Stevens R, Nuttin C, Martin JJ, Van Coster R, Seneca S, Roels F, Van Goethem G, Lofgren A, De Meirleir L (2012). Polymerase gamma deficiency (POLG): clinical course in a child with a two-stage evolution from infantile myocerebrohepatopathy spectrum to an Alpers syndrome and neuropathological findings of Leigh’s encephalopathy. European Journal of Paediatric Neurology, 16(5), 542-548. [doi: 10.1016/j.ejpn.2012.01.013]

  • Scalais E, Francois-Adant A, Nuttin C, Bachy A, Guerit JM (1998). Multimodality evoked potentials as a prognostic tool in term asphyxiated newborns. Electroencephalography and Clinical Neurophysiology, 108(2), 199-207. [doi: 10.1016/s0168-5597(97)00076-2]

  • Scalais E, Geron C, Pierron C, Cardillo S, Schlesser V, Mataigne F, Borde P, Regal L (2023). Would early versus late hydroxocobalamin dose intensification treatment prevent cognitive decline, macular degeneration and ocular disease in 5 patients with early-onset cblC deficiency? Molecular Genetics and Metabolism, 140(3), 107681. [doi: 10.1016/j.ymgme.2023.107681]

  • Scalais E, Nuttin C, Seneca S, Smet J, De Paepe B, Martin JJ, Stevens R, Pierart F, Battisti O, Lissens W, De Meirleir L, Van Coster R (2007). Infantile presentation of the mitochondrial A8344G mutation. European Journal of Neurology, 14(11), e3-5. [doi: 10.1111/j.1468-1331.2007.01926.x]

  • Scalais E, Osterheld E, Geron C, Pierron C, Chafai R, Schlesser V, Borde P, Regal L, Laeremans H, van Gassen KLI, van den Heuvel LPWJ, De Meirleir L (Under revision). Parenteral Hydroxocobalamin Dose Intensification in 5 Patients with Different Types of Early Onset Intracellular Cobalamin Defects: Clinical and Biochemical Responses. Journal of Inherited Metabolic Disease.